Nestle Health Science Investments

Nestle Health Science has invested in 12 companies and its latest investment was Cerecin on Jun 09, 2024

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Cerecin is a Singapore-based biotechnology company that researches and develops novel therapeutics for the treatment of Alzheimer’s disease and CNS disorders.
$3.7M
Jun 09, 2024
-
Timeline is a Switzerland-based health science company that develops products such as anti-aging nutritional supplements and accessories for the commercial market.
$66M
Jan 16, 2024
-
$312M
Sep 18, 2023
-
ProciseDx is a California-based medical device company that designs and distributes point-of-care diagnostic devices for the healthcare industry.
$13M
Jul 12, 2021
-
Enterome develops and commercializes therapies for the treatment of microbiome, cancer and metabolic diseases.
$52.6M
Jun 24, 2020
-

Frequently Asked Questions about Nestle Health Science

  1. What is Nestle Health Science investing in?

    Nestle Health Science has invested in 12 companies including Cerecin, Timeline and Humble Growth
  2. What company did Nestle Health Science invest in?

    Nestle Health Science invested in a total 12 companies including Cerecin, Timeline and Humble Growth
  1. What are the top 5 investments by Nestle Health Science?

    The top companies in which Nestle Health Science invested are Cerecin, Timeline, Humble Growth, ProciseDx and Enterome